Funding you earn now, next payment 09:00 UTC+0.0139%/8h= +15.2% APRpaid last 24h +0.048%
Price spread now: Injective against MEXC+10.488%7-day average — · you sell dearer than you buy
to open and closeno order booka leg has no order-book sample
Funding, last 4 days (all we have)—no history yet
+Price spread, last 7 days—no price history on both exchanges yet
=Together, before fees—needs both histories
Both sides work for this trade now. Funding pays +$4 a day on $10k at the current rate, and Injective is 10.488% dearer against MEXC than usual: you sell high and buy low: +$1,049 more if the spread goes back to zero (this spread has no 7-day history yet).
| Leg | Exchange | Price | Funding /8h | Each payment | Next in | OI | Vol 24h | Max lev |
|---|---|---|---|---|---|---|---|---|
| Long | MEXC GLD_USDT | 393.87 | 0.0081 | pay 0.0081% / 8h | 7h 27m | $104K | $99K | 20x |
| Short | Injective GLD/USDC PERP | 435.18 | 0.0220 | get 0.0028% / 1h | 27m 04s | $3K | $91 | 52x |
MEXC GLD_USDT
Injective GLD/USDC PERPFunding history
latest
Range statsloading…
Price spread between the two exchanges
Injective against MEXC. Falling: the short leg gains. Rising: it loses.latest
Price spreadloading…
Funding on every exchange
click an exchange to add or hide itlatest
How often the price spread is this wide · share of time at each level, last 7D show
Profit calculator
- Funding earned
- $29.19
- Price spread: +10.488% → 0.000%
- $1,048.82
- Slippage, 4 orders
- no order book: not counted
- Fee MEXC: 0 bp × 2 orders
- $0
- Fee Injective: 0.01 bp × 2 orders
- −$0.02
- Net
- $1,077.99
- Costs to cover
- 0.000%
- Break-even
- from the start
Slippage unknown: MEXC: live order book, 43 min ago; Injective: no order-book sample. Net counts fees only.
Cost to enter
taker fee + slippage from the mid, one side; closing costs about the same again| Leg | Half-spread | $10k | $100k | $1M | $5M |
|---|---|---|---|---|---|
| Buy MEXC live order book, 43 min ago | 8.10 bp | 790.2 bp −$790 | 1119.2 bp −$11.2K | 1208.9 bp −$120.9K | doesn't fit |
| Sell Injective no order-book sample | — | — | — | — | — |
Injective: no order-book sample. Either the market is below $100k of open interest and volume (not sampled), or the venue executes at an oracle price and its slippage is not modeled here: see the venue's docs.
GLD on 5 venues
lowest funding first. Swap a leg: a good short leg pays more funding and is priced higher.| Exchange | Funding /8h | Every | Price | Price vs long leg | OI | Vol 24h | Max lev | |
|---|---|---|---|---|---|---|---|---|
| Gate GLD_USDT | 0.0000% | 8h | 395.60 | +0.439% | $57K | $5K | 20x | as long as short |
| Arcus GLD-USD | +0.0040% | 1h | 394.08 | +0.053% | $296K | $502K | 25x | as long as short |
| Vest GLD-USD-PERP | +0.0046% | 1h | 393.72 | −0.038% | — | — | 25x | as long as short |
| MEXC GLD_USDTlong | +0.0081% | 8h | 393.87 | long leg | $104K | $99K | 20x | |
| Injective GLD/USDC PERPshort | +0.0220% | 1h | 435.18 | +10.488% | $3K | $91 | 52x |
Gate GLD_USDT
Arcus GLD-USD
Vest GLD-USD-PERP